Convective solute clearance via hemofiltration

Convective solute clearance via hemofiltration" does not refer to a specific molecule or receptor. Instead, it describes a physiological process used in renal replacement therapies such as continuous veno-venous hemofiltration (CVVH). In this process, blood is passed through a highly permeable membrane under pressure; water and small-to-medium-sized solutes are removed from the blood by convection—meaning they are dragged along with the flow of water across the membrane. This method efficiently clears substances up to about 20 kDa in size (e.g., urea, creatinine, phosphate), and can also remove some larger molecules more effectively than diffusion-based dialysis[2][3]. The process requires careful management of fluid balance using "replacement fluids" to avoid hypovolemia. It is not itself a drug target or molecular entity but rather a therapeutic technique applied in critical care nephrology for patients with acute kidney injury or fluid overload[1][2][3].\n\nKey points:\n- Not a molecule/receptor; it is a clinical technique/process.\n- No canonical abbreviation.\n- Not considered a therapeutic target in the sense of receptors/enzymes/transporters.\n- Safety concerns include risk for hypovolemia and filter clotting if not properly managed[1].\n- No interacting drugs or biomarkers specific to this "target."

Other names

HemofiltrationConvective clearanceSolute removal by convection